Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous Oxide for Treatment-Resistant Depression
NCT03283670Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Nov 2016
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitrous oxide in major depressive disorder (MDD), sponsored by Washington University School of Medicine. Started Nov 2016; status: completed.
02
Drugs
nitrous oxide
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03283670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03283670.